Health and medical research review

MTAA has contributed further to the Strategic Review of Health and Medical Research in NSW by responding to the range of issues which have been raised in the Discussion Paper.  While the Discussion Paper addresses some of the comments made by MTAA in previous submissions to the Review, MTAA believes that some recommendations could go further to truly drive the development of NSW as the national leader in the medical technology sector.

As we commented in our response to the Issues Paper, MTAA supports the vision for health and medical research expressed in the paper:

NSW will have a global reputation as a centre of excellence for health and medical research that supports a high quality health system and generates social and economic benefits to the State.

MTAA remains attracted to the dual focus of the vision – on the creation of research that supports the health system, and on the generation of economic benefits.  Without inclusion of industry as a partner in this endeavor, there cannot be the economic returns to the State.  Much of MTAA’s response to the Issues Paper examined mechanisms to support collaboration with industry and to encourage the translation of excellent research into products that can be brought to the market, both to benefit the NSW health system and its patients and to deliver flow-on economic benefits from the creation of a robust manufacturing sector that exports globally.

MTAA addressed the pillars and actions which are most relevant to the encouragement of a viable and robust medical technology sector in NSW.

  • Response to the discussion paper on NSW Health and Medical Research Strategic Review - 16 November 2011. Download here
  • Response to the NSW Health and Medical Research Strategic Review Issues Paper - 26 September 2011. Download here
  • Response to the exposure draft of the 2011 Strategic Roadmap for Australian Research Infrastructure from the Department of Innovation, Industry, Science and Research - 22 July 2011. Download here